» Articles » PMID: 26924801

Chitosan Nanoparticles Synthesis Caught in Action Using Microdroplet Reactions

Overview
Journal Sci Rep
Specialty Science
Date 2016 Mar 1
PMID 26924801
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

The ionic gelation process for the synthesis of chitosan nanoparticles was carried out in microdroplet reactions. The synthesis could be stopped instantaneously at different time points by fast dilution of the reaction mixture with DI water. Using this simple technique, the effect of temperature and reactant concentrations on the size and distribution of the nanoparticles formed, as a function of time, could be investigated by DLS and SEM. Results obtained indicated very early (1-5 s) nucleation of the particles followed by growth. The concentration of reactants, reaction temperature as well as time, were found to (severally and collectively) determine the size of nanoparticles and their distribution. Nanoparticles obtained at 4 °C were smaller (60-80 nm) with narrower size distribution. Simulation experiments using Comsol software showed that at 4 °C 'droplet synthesis' of nanoparticles gets miniaturised to 'droplet-core synthesis', which is being reported for the first time.

Citing Articles

Assessment of the Biocontrol Efficacy of Silver Nanoparticles Synthesized by Against Infected L. Germination.

Heikal Y, Shweqa N, Abdelmigid H, Alyamani A, Soliman H, El-Naggar N Life (Basel). 2025; 14(12.

PMID: 39768268 PMC: 11676777. DOI: 10.3390/life14121560.


Synthesis of chitosan nanoparticles (CSNP): effect of CH-CH-TPP ratio on size and stability of NPs.

Des Bouillons-Gamboa R, Montes de Oca G, Baudrit J, Rios Duarte L, Lopretti M, Renteria Urquiza M Front Chem. 2024; 12:1469271.

PMID: 39618968 PMC: 11604443. DOI: 10.3389/fchem.2024.1469271.


Myco-Biosynthesis of Silver Nanoparticles, Optimization, Characterization, and In Silico Anticancer Activities by Molecular Docking Approach against Hepatic and Breast Cancer.

El-Naggar N, Shweqa N, Abdelmigid H, Alyamani A, Elshafey N, Soliman H Biomolecules. 2024; 14(9).

PMID: 39334936 PMC: 11429812. DOI: 10.3390/biom14091170.


An Investigation into the Effects of Processing Factors on the Properties and Scaling-Up Potential of Propranolol-Loaded Chitosan Nanogels.

Ho H, Day R, Craig D Pharmaceutics. 2024; 16(5).

PMID: 38794324 PMC: 11125439. DOI: 10.3390/pharmaceutics16050662.


A sustainable green-approach for biofabrication of chitosan nanoparticles, optimization, characterization, its antifungal activity against phytopathogenic Fusarium culmorum and antitumor activity.

El-Naggar N, Shiha A, Mahrous H, Mohammed A Sci Rep. 2024; 14(1):11336.

PMID: 38760441 PMC: 11101436. DOI: 10.1038/s41598-024-59702-3.


References
1.
Patel T, Zhou J, Piepmeier J, Saltzman W . Polymeric nanoparticles for drug delivery to the central nervous system. Adv Drug Deliv Rev. 2012; 64(7):701-5. PMC: 3323692. DOI: 10.1016/j.addr.2011.12.006. View

2.
Koukaras E, Papadimitriou S, Bikiaris D, Froudakis G . Insight on the formation of chitosan nanoparticles through ionotropic gelation with tripolyphosphate. Mol Pharm. 2012; 9(10):2856-62. DOI: 10.1021/mp300162j. View

3.
Mertins O, Dimova R . Insights on the interactions of chitosan with phospholipid vesicles. Part I: Effect of polymer deprotonation. Langmuir. 2013; 29(47):14545-51. DOI: 10.1021/la403218c. View

4.
Prabaharan M . Chitosan-based nanoparticles for tumor-targeted drug delivery. Int J Biol Macromol. 2014; 72:1313-22. DOI: 10.1016/j.ijbiomac.2014.10.052. View

5.
Agnihotri S, Mallikarjuna N, Aminabhavi T . Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J Control Release. 2004; 100(1):5-28. DOI: 10.1016/j.jconrel.2004.08.010. View